arrow
Z

Zsolt Horváth

University of Debrecen
H指数:28
被引数:8,455

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparative assessment of intratumoral sunitinib distribution and therapeutic response in matched primary and metastatic tumor models

对配对的肿瘤原发灶和转移灶模型中肿瘤内舒尼替尼分布与治疗效果的比较评估

2026-08-220
OAAI
Development of experimental isolated lung perfusion model using surgically resected tumorous human lobes

使用手术切除的肿瘤性人肺叶建立实验性离体肺灌注模型

2026-07-210
OA
Distant metastases of melanoma exhibit varying extent of intrapatient proteogenomic heterogeneity

黑色素瘤的远处转移表现出不同程度的患者内蛋白质组异质性。

2025-09-280
OAAI
Improvements in cancer survival in Hungary: a nationwide epidemiology study between 2011-2019 based on a health insurance fund database
2025-04-030
OAAI
Improvement in breast cancer survival across molecular subtypes in Hungary between 2011 and 2020: a nationwide, retrospective study
2025-03-310
OAAI
Revising cancer incidence in a Central European country: a Hungarian nationwide study between 2011-2019 based on a health insurance fund database
2024-10-011
OAAI
Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011-2020
2023-09-186
OAAI
A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naive, cisplatin-ineligible urothelial cancer
2023-06-012
OAAI
Camizestrant, a next generation oral SERD vs fulvestrant in post-menopausal women with advanced ER-positive HER2-negative breast cancer: Results of the randomized, multi-dose Phase 2 SERENA-2 trial
2023-03-0136
PRE
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
LANCET
IF88.5
2019-11-011.4K
PREAI